LAVES ARZNEIMITTEL GMBH has a total of 12 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Germany, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are CORTENDO INVEST AB, METABOLIC PHARMACEUTICALS PTY LTD and ASTION PHARMA AS.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Laves Hans-Georg | 8 |
#2 | Thomsen Anne | 6 |
#3 | Grimmecke Hans-Dieter | 3 |
#4 | Kalousek Markus B | 3 |
#5 | Seibold Frank | 3 |
Publication | Filing date | Title |
---|---|---|
DE10158601A1 | Use of GABA to treat intestinal inflammation | |
DE19712977A1 | Use of gamma-aminobutyric acid | |
DE19712634A1 | Low molecular fraction derived from E. coli extract | |
DE4422859A1 | Aqueous cell extracts from mycobacteria |